Danaher Partners with Beijing’s Changping District to Accelerate Science and Technology Innovation Center
US-headquartered Danaher (NYSE: DHR), a Fortune 500 science and technology innovator, has entered into a...
Deals
ClouDr Partners with Hong Kong Magicure Medical Center to Enhance Cross-Border Medical Access
Hangzhou Kang Ming Information Technology Co., Ltd, known as “ClouDr” (HKG: 9955), has entered into...
Novo Nordisk and Broad Institute Collaborate on Diabetes and Cardiometabolic Research
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has announced a collaboration with the US academic...
uBriGene and YolTech Therapeutics Join Forces to Advance mRNA Therapy and Gene Therapy
China-based uBriGene Biosciences Inc., a prominent contract development and manufacturing organization (CDMO) specializing in cell...
Sino Medical Sciences Technology to Acquire Majority Stake in US Endovascular Device Firm eLum
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced plans to acquire a 72.73%...
Sinovac Biotech Directors Reject Alternative Liquidity’s Lowball Tender Offer
China-based Sinovac Biotech Ltd. (NASDAQ: SVA) announced that its Board of Directors has unanimously determined...
Abbott to Acquire Insulin Management Firm Bigfoot Biomedical
Healthcare giant Abbott (NYSE: ABT) has announced an agreement to purchase Bigfoot Biomedical, a company...
Bristol-Myers Squibb Acquires Rights to Zenas BioPharma’s Obexelimab for Autoimmune Diseases
US pharmaceutical major Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a licensing and cooperation...
MGI Tech Partners with Eight Companies to Expand G99-Based Sequencing Applications
China-based MGI Tech, a subsidiary of BGI Group (SHE: 300676), has entered into cooperation agreements...
ImmuneOnco Biopharmaceuticals Begins Trading on HKEX with Successful IPO
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) marked its debut on the Hong Kong Stock...
Bloomage Biotech Terminates Joint Venture with Medytox Inc. for Botulinum Toxin Development
China-based Bloomage Biotech (SHA: 688363) has revealed that a termination agreement has been signed with...
Pilot Gene Technology Secures $13.8 Million in Series B Financing for Diagnostic Expansion
China-based diagnostic reagents specialist, Pilot Gene Technology (Hangzhou) Co., Ltd, has reportedly raised RMB 100...
Amgen and Horizon Therapeutics Reach Agreement with FTC to Proceed with Acquisition
Amgen (NASDAQ: AMGN) and Horizon Therapeutics (NASDAQ: HZNP) have announced a consent order agreement with...
Shanghai Biotech Cataya Secures $35 Million in Series B Financing for Synthetic Biology
Shanghai-based biotech company Cataya, which specializes in synthetic biology, has reportedly raised RMB 250 million...
XtalPi Partners with Parthenon Therapeutics to Harness AI for Solid Tumor Antibody Development
Sino-US artificial intelligence (AI) firm XtalPi (QuantumPharm, HKG: 2228) has entered into a strategic partnership...
EOC Pharma Group and Nanopeptide Biotechnology Forge Partnership for siRNA Drug Development
China-based EOC Pharma Group has announced a strategic partnership with fellow country siRNA firm, Nanopeptide...
Huadong Medicine Secures Exclusive Rights to MC2 Therapeutics’ Plaque Psoriasis Therapy in China
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced a licensing agreement with Denmark-headquartered MC2...
Innovac Therapeutics Secures $18 Million in Pre-Series A Financing for mRNA Vaccine Development
Innovac Therapeutics, a Massachusetts-based mRNA vaccine developer, has announced the successful completion of its Pre-Series...
Watchmaker Genomics and Exact Sciences Corporation Ink Deal to Advance TAPS Technology
US-based Watchmaker Genomics has announced a multi-year, co-exclusive agreement with compatriot firm Exact Sciences Corporation...
XtalPi Inc. Partners with Edelweiss Connect to Revolutionize Skincare Safety Assessment
Sino-US artificial intelligence (AI) firm XtalPi (QuantumPharm, HKG: 2228) has announced a strategic partnership with...